Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on EZT FAM Impurity Control. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102066318A reveals a low-catalyst hydrogenation process for high-purity Ezetimibe, offering significant cost reduction and supply chain reliability for API manufacturers.